Jinyu 生物股份
19 significant filings since 29 May 2026: 1 on share pledge, 12 on buyback and 3 on dividend, and 3 other kinds. The latest, on 8 Sep 2026: 生物股份关于股份回购实施结果暨股份变动的公告. On 6 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 50.60% to 80.39% from the same period a year earlier.
自 29 May 2026 起有 19 份重大公告：share pledge 1 份、buyback 12 份、dividend 3 份，另有 3 类。最新一份（8 Sep 2026）：生物股份关于股份回购实施结果暨股份变动的公告。6 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 50.60% 至 80.39%。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 0 brokers | 0 brokers |
| 7 days ago | 0 brokers | 0 brokers |
| 30 days ago | 1 broker | 1 broker |
| 60 days ago | 1 broker | 1 broker |
| 90 days ago | 1 broker | 1 broker |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus was 0.29 in both May 2025 and Nov 2025. The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
| Last 90 days | ▲ 0 ▼ 0 = 0 | ▲ 0 ▼ 0 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
| Year | Filed | Consensus | Brokers 券商 | Reported 实际 | Surprise 偏差 |
|---|---|---|---|---|---|
| FY2020 | 23 Apr 2021 | 0.36 | 3 | 0.36 | +0.0% |
| FY2019 | 30 Mar 2020 | 0.19 | 3 | 0.20 | +5.3% |
Surprise is reported EPS against the consensus on the day before the annual report was filed. 偏差为实际每股收益与年报披露前一日一致预期之差。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 1 and FY2024 had 0.